877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Pyrazoles, matrixscientific.com, Drugs acting on the gastrointestinal system and metabolism, Opioids, Five-membered rings, Psychoactive drugs, Antiobesity drugs

Categories

Analgesics (1)
Anorectics (1)
Anxiogenics (1)
Cannabinoids (1)
Cannabis (1)
Cyclic compounds (1)
Drugs acting on the nervous system (1)
Opioid antagonists (1)
Opioid receptor ligands (1)
Pharmaceuticals (1)
Piperidines (1)
Pyrazolecarboxamides (1)
Six-membered rings (1)

Rimonabant (168273-06-1, 158681-13-1)  
Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) was an anorectic antiobesity drug that was first approved in Europe in 2006 but was withdrawn worldwide in 2008 due to serious psychiatric side effects; it was never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1 and was the first drug approved in that class.
Related searches
Pyrazoles
matrixscientific.com
Drugs acting on the gastrointestinal system and metabolism
Opioids
Five-membered rings
Psychoactive drugs
Antiobesity drugs